These genes are primarily related to complement deficiency, activation of the type I interferon (IFN) pathway, disruption of B cell and T cell tolerance and metabolic pathways, which reveal the multifaceted nature of systemic lupus erythematosus (SLE) pathogenesis. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.